NewsMarkets

Business

Bayer Wins St. Louis Roundup Trial

A jury rejected cancer claims against the herbicide, bolstering the company's effort to settle tens of thousands of similar US lawsuits.

2 publishers · 2 articles · first seen 30 Oct 2026 · updated 2h ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

The story so far

2 publishers have covered this in 2 articles since 30 Oct 2026. Bloomberg Markets published first, on 30 October at 00:46 UTC; Deutsche Welle followed 1h 54m later. The most recent article, from Deutsche Welle, appeared on 30 October at 02:40 UTC.

Outlets reporting it: Bloomberg Markets (major outlet), Deutsche Welle.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. Bayer Wins St. Louis Roundup Trial, Bolstering Settlement Push Bloomberg Markets ·
  2. Bayer wins Roundup cancer trial after Supreme Court ruling Deutsche Welle

In this story

  • Bayer AG
  • St. Louis
Embed this story

Paste this into any web page to show the live odds, with a link back here.